Brigimadlin

Brigimadlin
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T69923-1mg 1 mg

7 - 10 business days*

152.00€
TGM-T69923-5mg 5 mg

7 - 10 business days*

270.00€
TGM-T69923-1mL 1 ml (1 mL * 10 mM (in DMSO)) - - -

7 - 10 business days*

352.00€
TGM-T69923-10mg 10 mg

7 - 10 business days*

370.00€
TGM-T69923-25mg 25 mg

7 - 10 business days*

608.00€
TGM-T69923-50mg 50 mg

7 - 10 business days*

925.00€
TGM-T69923-100mg 100 mg - - -

7 - 10 business days*

1,383.00€
 
Description: Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein... more
Product information "Brigimadlin"
Description: Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase MDM2-p53 antagonist with antitumor activity.Brigimadlin can be used to study metastatic BTC, PDAC, lung adenocarcinoma, or bladder cancer. Target: MDM-2/p53, E1/E2/E3 Enzyme, Mdm2, p53. Smiles: C(N1[C@@]2([C@H]([C@]3([C@@]1(CC=4N3N=C5C4C=CC(C(O)=O)=C5C)[H])[H])C6=C(F)C(Cl)=CC=C6)C=7C(NC2=O)=CC(Cl)=CC7)C8CC8. References: Hao X, et al. BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models. Neuro Oncol. 2023 May 4,25(5):913-926.
Keywords: BI 907828 , BI907828 , BI-907828
Supplier: TargetMol
Supplier-Nr: T69923

Properties

MW: 591.46 D
Formula: C31H25Cl2FN4O3
Format: 32160405

Database Information

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Brigimadlin"
Write a review
or to review a product.
Viewed